Status:
COMPLETED
Inhalation of Vapor With Medication (Diclofenac Sodium, Menthol, Methyl Salicylate and N-Acetyl Cysteine) Reduces Oxygen Need and Hospital Stay in COVID-19 Patients - A Case Control Study
Lead Sponsor:
Sher-E-Bangla Medical College
Conditions:
Covid19
Eligibility:
All Genders
20+ years
Phase:
PHASE1
Brief Summary
Background: In the midst of the devastating COVID pandemic where there is no specific and effective treatment, traditional therapy may help to ease the patient's suffering. Inhalation of vapor (VP) is...
Eligibility Criteria
Inclusion
- Patient must be COVID 19 positive and having a lack of oxygen saturation.
Exclusion
- All the patients who do not covid infected.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT04900129
Start Date
December 1 2020
End Date
December 30 2020
Last Update
May 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HN Sarker
Barishal, Bangladesh, 1207